Atlas Trials

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Clinical trial NCT04045522 · UNKNOWN

Trial details

NCT number
NCT04045522
Sponsor
Shengjing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2019-09-01
Primary completion
2021-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.